Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.

Cheng JM, Hiemstra JL, Schneider SS, Kaufman BA, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM.

Prog Clin Biol Res. 1994;385:43-9.

PMID:
7972236
2.

Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas.

Cheng JM, Hiemstra JL, Schneider SS, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM.

Nat Genet. 1993 Jun;4(2):191-4.

PMID:
8102299
3.
4.

Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.

Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voûte PA, Westerveld A, Versteeg R.

Nat Genet. 1993 Jun;4(2):187-90. Erratum in: Nat Genet 1993 Aug;4(4):431.

PMID:
8102298
5.

Analysis of genomic imprinting at 1p35-36 in neuroblastoma.

Hogarty MD, Maris JM, White PS, Guo C, Brodeur GM.

Med Pediatr Oncol. 2001 Jan;36(1):52-5. Review.

PMID:
11464906
6.

Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.

Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM.

Cancer Res. 1992 Apr 1;52(7):1780-5.

7.

Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells.

Grandinetti KB, Spengler BA, Biedler JL, Ross RA.

Oncogene. 2006 Feb 2;25(5):706-12.

PMID:
16278682
8.

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.

Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voûte PA, Versteeg R.

N Engl J Med. 1996 Jan 25;334(4):225-30.

9.

Allelotype of neuroblastoma.

Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K, Yokota J.

Oncogene. 1995 Nov 2;11(9):1829-34.

PMID:
7478611
10.

Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group.

Christiansen H, Delattre O, Fuchs S, Theobald M, Christiansen NM, Berthold F, Lampert F.

Prog Clin Biol Res. 1994;385:19-25.

PMID:
7972212
11.

Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.

Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R.

Oncogene. 1995 Jan 19;10(2):291-7.

PMID:
7838528
12.
13.

Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.

Spieker N, Beitsma M, Van Sluis P, Chan A, Caron H, Versteeg R.

Genes Chromosomes Cancer. 2001 Jun;31(2):172-81.

PMID:
11319804
14.

Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.

Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H, et al.

Cancer Res. 1995 Feb 15;55(4):721-6.

15.

Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.

Ohtsu K, Hiyama E, Ichikawa T, Matsuura Y, Yokoyama T.

Clin Cancer Res. 1997 Jul;3(7):1221-8.

16.

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.

Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N.

N Engl J Med. 1999 Jun 24;340(25):1954-61.

17.

Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.

Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Fukuba I, Matsuura Y, Yokoyama T.

Med Pediatr Oncol. 2001 Jan;36(1):67-74.

PMID:
11464909
18.

Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification.

Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugières L, Voûte PA, Westerveld A, et al.

Hum Mol Genet. 1995 Apr;4(4):535-9.

PMID:
7633401
19.

The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.

Gehring M, Berthold F, Edler L, Schwab M, Amler LC.

Cancer Res. 1995 Nov 15;55(22):5366-9.

20.

Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma.

Wimmer K, Zhu XX, Lamb BJ, Kuick R, Ambros PF, Kovar H, Thoraval D, Motyka S, Alberts JR, Hanash SM.

Oncogene. 1999 Jan 7;18(1):233-8.

Supplemental Content

Support Center